Literature DB >> 21937443

Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes.

Claudia Bertuccio1, Delma Veron, Pardeep K Aggarwal, Lawrence Holzman, Alda Tufro.   

Abstract

The transmembrane protein nephrin is an essential component of slit diaphragms, the specialized cell junctions that link podocyte foot processes. Podocytes are epithelial cells that surround the glomerular capillaries in the kidney and are necessary for the organ-filtering function. Nephrin signaling complex transduces extracellular cues to the podocyte cytoskeleton and regulates podocyte shape and function. Vascular endothelial growth factor A (VEGF-A) is a required growth factor produced and secreted by podocytes. Accumulating evidence suggests a cross-talk between VEGF-A and nephrin signaling pathways. We previously showed that in vivo nephrin associates with VEGF receptor-2 (VEGFR2), the signaling receptor for VEGF-A. In the present work, we characterized the interaction between nephrin and VEGFR2 in cultured cells and in vitro. We demonstrate that nephrin-VEGFR2 interaction is direct using mass spectrometry, immunoprecipitation, GST-binding assays, and blot overlay experiments. This interaction occurs through VEGFR2 and nephrin cytoplasmic domains. Nephrin-VEGFR2 interaction is modulated by tyrosine phosphorylation of both cytoplasmic domains. Furthermore, the nephrin-VEGFR2 complex involves Nck and actin. VEGF-A signaling via this complex results in decreased cell size. We provide evidence that this multiprotein interaction occurs in cultured podocytes. We propose that the nephrin-VEGFR2 complex acts as a key mediator to transduce local VEGF-A signals to the podocyte actin cytoskeleton, regulating the foot process structure and glomerular filter integrity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937443      PMCID: PMC3220571          DOI: 10.1074/jbc.M111.241620

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm.

Authors:  K Tryggvason
Journal:  J Am Soc Nephrol       Date:  1999-11       Impact factor: 10.121

2.  MYO1E mutations and childhood familial focal segmental glomerulosclerosis.

Authors:  Caterina Mele; Paraskevas Iatropoulos; Roberta Donadelli; Andrea Calabria; Ramona Maranta; Paola Cassis; Simona Buelli; Susanna Tomasoni; Rossella Piras; Mira Krendel; Serena Bettoni; Marina Morigi; Massimo Delledonne; Carmine Pecoraro; Isabella Abbate; Maria Rosaria Capobianchi; Friedhelm Hildebrandt; Edgar Otto; Franz Schaefer; Fabio Macciardi; Fatih Ozaltin; Sevinc Emre; Tulin Ibsirlioglu; Ariela Benigni; Giuseppe Remuzzi; Marina Noris
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

3.  Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.

Authors:  P Hovind; L Tarnow; P B Oestergaard; H H Parving
Journal:  Kidney Int Suppl       Date:  2000-04       Impact factor: 10.545

4.  Primary structure of mouse and rat nephrin cDNA and structure and expression of the mouse gene.

Authors:  Heli Putaala; Kirsi Sainio; Hannu Sariola; Karl Tryggvason
Journal:  J Am Soc Nephrol       Date:  2000-06       Impact factor: 10.121

5.  Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.

Authors:  D Veron; C A Bertuccio; A Marlier; K Reidy; A M Garcia; J Jimenez; H Velazquez; M Kashgarian; G W Moeckel; A Tufro
Journal:  Diabetologia       Date:  2011-02-12       Impact factor: 10.122

6.  Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling.

Authors:  Karen Sison; Vera Eremina; Hans Baelde; Wang Min; Masanori Hirashima; I George Fantus; Susan E Quaggin
Journal:  J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 10.121

7.  Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.

Authors:  Delma Veron; Kimberly J Reidy; Claudia Bertuccio; Jason Teichman; Guillermo Villegas; Juan Jimenez; Wa Shen; Jeffrey B Kopp; David B Thomas; Alda Tufro
Journal:  Kidney Int       Date:  2010-03-10       Impact factor: 10.612

8.  A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.

Authors:  T Takahashi; S Yamaguchi; K Chida; M Shibuya
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

9.  PKC alpha mediates beta-arrestin2-dependent nephrin endocytosis in hyperglycemia.

Authors:  Ivo Quack; Magdalena Woznowski; Sebastian A Potthoff; Romy Palmer; Eva Königshausen; Sema Sivritas; Mario Schiffer; Johannes Stegbauer; Oliver Vonend; Lars Christian Rump; Lorenz Sellin
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

10.  Induction of podocyte VEGF164 overexpression at different stages of development causes congenital nephrosis or steroid-resistant nephrotic syndrome.

Authors:  Delma Veron; Kimberly Reidy; Arnaud Marlier; Claudia Bertuccio; Guillermo Villegas; Juan Jimenez; Michael Kashgarian; Alda Tufro
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

View more
  37 in total

1.  Tyrosine Phosphorylation of CD2AP Affects Stability of the Slit Diaphragm Complex.

Authors:  Irini Tossidou; Beina Teng; Kirstin Worthmann; Janina Müller-Deile; Tilman Jobst-Schwan; Christian Kardinal; Patricia Schroder; Patricia Bolanos-Palmieri; Hermann Haller; Jonas Willerding; Dana M Drost; Laura de Jonge; Thomas Reubold; Susanne Eschenburg; Ruth I Johnson; Mario Schiffer
Journal:  J Am Soc Nephrol       Date:  2019-06-24       Impact factor: 10.121

Review 2.  From Glomerular Endothelium to Podocyte Pathobiology in Preeclampsia: a Paradigm Shift.

Authors:  Rosanne J Turner; Kitty W M Bloemenkamp; Marlies E Penning; Jan Anthonie Bruijn; Hans J Baelde
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

3.  Podocyte penetration of the glomerular basement membrane to contact on the mesangial cell at the lesion of mesangial interposition in lupus nephritis: a three-dimensional analysis by serial block-face scanning electron microscopy.

Authors:  Takashi Takaki; Nobuhiko Ohno; Sei Saitoh; Masaaki Nagai; Kensuke Joh
Journal:  Clin Exp Nephrol       Date:  2019-02-08       Impact factor: 2.801

4.  Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction.

Authors:  Kimberly J Reidy; Pardeep K Aggarwal; Juan J Jimenez; David B Thomas; Delma Veron; Alda Tufro
Journal:  Am J Pathol       Date:  2013-08-14       Impact factor: 4.307

Review 5.  Tyrosine kinase inhibitors: their on-target toxicities as potential indicators of efficacy.

Authors:  Devron R Shah; Rashmi R Shah; Joel Morganroth
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

6.  Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice.

Authors:  Delma Veron; Pardeep K Aggarwal; Heino Velazquez; Michael Kashgarian; Gilbert Moeckel; Alda Tufro
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

Review 7.  Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease.

Authors:  Omar C Logue; Jeremy W D McGowan; Eric M George; Gene L Bidwell
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-09       Impact factor: 2.894

Review 8.  Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.

Authors:  Stacy A Johnson; Robert F Spurney
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-02

9.  Effect of simvastatin on the expression of nephrin, podocin, and vascular endothelial growth factor (VEGF) in podocytes of diabetic rat.

Authors:  Shujun Chen; Haiping Chen; Qi Liu; Qing Ma
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism.

Authors:  Taylor W Harvey; Jason E Engel; Alejandro R Chade
Journal:  Am J Nephrol       Date:  2016-03-02       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.